News

Mayo Clinic Laboratories introduces an advancement in the management of Crohn's disease with the release of a new laboratory test that measures Risankizumab levels in patients. This test will advance the therapeutic monitoring of Crohn's disease, enabling personalized treatment approaches.

By Suzanne Ferguson • April 16, 2024

As we prepare to celebrate this year's Lab Week, the Mayo Collaborative Services Education team not only wants to highlight your important work as medical laboratory professionals and pathologists, but also help you feel more confident in your role by sharing the following educational resources that may give you additional knowledge and opportunities to advance in your career. 

By Cory Pedersen • April 15, 2024

Medical Laboratory Professionals Week, also known as Lab Week, provides us with the opportunity to increase our understanding of and appreciation for clinical laboratory personnel. We celebrate their efforts to provide critical answers for patients every day and drive innovation in the field of medicine.

By Carly Mouzes • April 15, 2024

In recent articles, Mayo Clinic Laboratories emphasizes the transformative potential of recognizing and leveraging the capabilities of a hospital laboratory. With more touchpoints than any other outpatient service line, the laboratory is full of opportunity to enhance local healthcare delivery and bolster a hospital’s financial stability.

By Luci Gens • March 28, 2024

Join Mayo Clinic Laboratories at the American Academy of Neurology Annual Meeting 2024.

By Carly Mouzes • March 25, 2024

William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his latest article, he describes the untapped potential of hospital laboratories and how health systems can maximize the value of their labs.

By Luci Gens • March 21, 2024

Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, joins “Becker’s Healthcare Podcast” to discuss organizational alignment during times of change. She shares her expertise on creating transparency, fostering open communication, and using data to stay on track with business goals.

By Luci Gens • March 14, 2024

William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his first article, Dr. Morice reflects on the diagnostic landscape and predicts trends that could influence the market in 2024.

By Luci Gens • March 7, 2024

A winter storm is occurring in the Northeast which may impact specimen transport. The winter storm is expected to spread snow, strong winds, and create possible blizzard conditions which could impact courier pickups and route delays. We are monitoring the situation and will implement contingency plans as needed to avoid any potential delays. Clients should expect to be contacted directly by the couriers should any routes be modified or canceled. 

By Mayo Clinic Laboratories • February 13, 2024

Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features. With this information, clinicians can make more informed decisions about hospitalization, monitoring, more frequent checkups, and even early delivery.

By Cory Pedersen • January 30, 2024

Due to a major weather impact at the FedEx hub in Memphis, Tennessee, the Mayo Clinic Laboratories’ Global Logistics team is working to minimize any client impacts. Please visit our website for updates. For any immediate needs, please contact Customer Service at 800-533-1710 and ask to be forwarded to the Global Logistics specialist. 

By Mayo Clinic Laboratories • January 22, 2024

Globally, five million deaths are associated with bacterial antimicrobial resistance each year, but the complexity of the issue is there is no single solution because we need to use antibiotics. It’s about finding a different way to live with it.

By Elizabeth Harty • January 11, 2024

There is a major weather system moving across the United States that may impact specimen transport. Winter storm Finn is expected to spread snow, strong winds, and create possible blizzard conditions into the Plains and Midwest. This may impact courier pickups and cause delays at major hubs (Fed Ex and UPS). We are monitoring and tracking this situation with our logistics partners and are prepared to adjust to minimize challenges. Clients should expect to be contacted directly by the couriers should any routes be modified or canceled.

By Mayo Clinic Laboratories • January 9, 2024